文献速递心脏核医学

动态CZT显像在射血分数保留的心力衰竭中的预后作用

Prognostic Role of Dynamic CZT Imaging in Heart Failure With Preserved Ejection Fraction.
PubMed 文献 · Clin Nucl Med · 2023-06-08

研究纳入112例非阻塞性冠心病患者,基线行动态CZT-SPECT、超声心动图和冠状动脉CT血管造影,随访12个月。MFR≤1.62和NT-proBNP≥760.5 pg/mL是不良心衰进展的独立预测因素。

要点

  • MFR≤1.62是非阻塞性冠心病患者HFpEF不良结局的独立预测因素(OR 2.801)。
  • NT-proBNP≥760.5 pg/mL亦为独立预测因素(OR 1.87)。
  • 动态CZT显像获得的MFR可用于HFpEF风险分层。

核心结论

  • 动态CZT显像获得的MFR≤1.62和NT-proBNP≥760.5 pg/mL可识别12个月随访期间HFpEF发生和进展高风险患者,独立于基线临床参数和影像变量。

研究设计与样本

  • 研究纳入112例非阻塞性冠心病患者(70例男性;中位年龄62.5[57.0;69.0]岁),基线行动态CZT-SPECT、超声心动图和冠状动脉CT血管造影,随访12个月。

主要发现

  • 按不良事件分组:组1为有不良结局患者(n=25),组2为无不良结局患者(n=87)。
  • ROC分析确定预测不良结局的截断值:MFR≤1.62(AUC 0.884;P<0.001)、负荷MBF≤1.35 mL/min/g(AUC 0.750;P<0.001)、NT-proBNP≥760.5 pg/mL(AUC 0.764;P=0.001)。
  • 单因素分析显示2型糖尿病(P=0.044)、MFR≤1.62(P=0.014)、负荷MBF≤1.35 mL/min/g(P=0.012)、NT-proBNP≥760.5 pg/mL(P=0.018)和舒张功能障碍(P=0.009)是HFpEF发生和进展的潜在危险因素。
  • 多因素分析显示NT-proBNP≥760.5 pg/mL(OR 1.87;95%CI 1.17-3.62;P=0.027)和MFR≤1.62(OR 2.801;95%CI 1.19-6.55;P=0.018)是不良结局的独立预测因素。

关键数值与推荐

  • MFR≤1.62预测不良结局的AUC为0.884(P<0.001)。
  • 负荷MBF≤1.35 mL/min/g预测不良结局的AUC为0.750(P<0.001)。
  • NT-proBNP≥760.5 pg/mL预测不良结局的AUC为0.764(P=0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of the study was to evaluate the prognostic role of myocardial flow reserve (MFR) and myocardial blood flow (MBF) estimates obtained with dynamic cadmium-zinc-telluride (CZT) imaging in the development and progression of heart failure with preserved ejection fraction (HFpEF) in patients with nonobstructive coronary artery disease (CAD) during a 12-month follow-up period. PATIENTS AND METHODS: A total of 112 patients (70 men; median age of 62.5 [57.0; 69.0] years) with nonobstructive coronary artery disease were enrolled in the study. Dynamic CZT-SPECT, echocardiography, and coronary CT angiography studies were performed baseline. RESULTS: Distribution of patients was performed by adverse events: group 1 comprised patients with adverse outcomes (n = 25), and group 2 comprised those without it (n = 87). Based on receiver operating characteristic analysis, the levels of MFR ≤1.62 (area under the curve [AUС], 0.884; Р < 0.001), stress-MBF ≤1.35 mL/min per gram (AUС, 0.750; Р < 0.001), and NT-proBNP ≥760.5 pg/mL (AUС, 0.764; Р = 0.001) were identified as cutoff values to predict adverse outcomes. Univariate analysis revealed that type 2 diabetes mellitus ( P = 0.044), the levels of MFR ≤1.62 ( P = 0.014), stress-MBF ≤1.35 mL/min per gram ( P = 0.012), NT-proBNP ≥760.5 pg/mL ( P = 0.018), and diastolic dysfunction ( P = 0.009) were potential risk factors for the development and progression of HFpEF. Multivariate analysis demonstrated that the values of NT-proBNP ≥760.5 pg/mL (odds ratio, 1.87; 95% confidence interval, 1.17-3.62; P = 0.027) and MFR ≤1.62 (odds ratio, 2.801; 95% confidence interval, 1.19-6.55; P = 0.018) were independent predictors of adverse outcomes. CONCLUSIONS: Our data suggest that reduced MFR ≤1.62 obtained with dynamic CZT imaging and overexpression of NT-proBNP ≥760.5 pg/mL can individuate patients at high risk of development and progression of HFpEF during a 12-month follow-up period, independently of baseline clinical parameters and imaging variables.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kopeva KV, Mochula AV, Maltseva AN, et al. Prognostic Role of Dynamic CZT Imaging in Heart Failure With Preserved Ejection Fraction. Clin Nucl Med. 2023. PMID: 37290425. doi:10.1097/RLU.0000000000004738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。